Detalhe da pesquisa
1.
[Febrile cholestatic jaundice as an initial manifestation of Hodgkin's disease]. / Ictericia febril colestásica como forma de presentación de linfoma de Hodgkin.
Medicina (B Aires)
; 74(1): 60-1, 2014.
Artigo
em Espanhol
| MEDLINE | ID: mdl-24561844
2.
[Early use of tocilizumab in hospitalized patients with severe and critical COVID-19 in the Province of Buenos Aires: a multicentric study]. / Utilización precoz de tocilizumab en pacientes internados con COVID-19 grave y crítica: un estudio multicéntrico en la Provincia de Buenos Aires.
Medicina (B Aires)
; 83(2): 190-201, 2023.
Artigo
em Espanhol
| MEDLINE | ID: mdl-37094187
3.
Protection of homologous and heterologous boosters after primary schemes of rAd26-rAd5, ChAdOx1 nCoV-19 and BBIBP-CorV during the omicron outbreak in adults of 50 years and older in Argentina: a test-negative case-control study.
Lancet Reg Health Am
; 27: 100607, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37808936
4.
Effectiveness of BBIBP-CorV, BNT162b2 and mRNA-1273 vaccines against hospitalisations among children and adolescents during the Omicron outbreak in Argentina: A retrospective cohort study.
Lancet Reg Health Am
; 13: 100316, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35872665
5.
Timing of convalescent plasma administration and 28-day mortality in COVID-19 pneumonia.
J Investig Med
; 70(5): 1258-1264, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35135872
6.
Immune Response to SARS-CoV-2 Third Vaccine in Patients With Rheumatoid Arthritis Who Had No Seroconversion After Primary 2-Dose Regimen With Inactivated or Vector-Based Vaccines.
J Rheumatol
; 49(12): 1385-1389, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36182107
7.
Immunogenicity and reactogenicity of heterologous immunization against SARS CoV-2 using Sputnik V, ChAdOx1-S, BBIBP-CorV, Ad5-nCoV, and mRNA-1273.
Cell Rep Med
; 3(8): 100706, 2022 08 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-35926505
8.
Estimating COVID-19 cases and outbreaks on-stream through phone calls.
R Soc Open Sci
; 8(3): 202312, 2021 Mar 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-33959370
9.
Effectiveness of the first component of Gam-COVID-Vac (Sputnik V) on reduction of SARS-CoV-2 confirmed infections, hospitalisations and mortality in patients aged 60-79: a retrospective cohort study in Argentina.
EClinicalMedicine
; 40: 101126, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34541480
10.
Risk factors for COVID-19 mortality: The effect of convalescent plasma administration.
PLoS One
; 16(4): e0250386, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33914780
11.
Sputnik V vaccine elicits seroconversion and neutralizing capacity to SARS-CoV-2 after a single dose.
Cell Rep Med
; 2(8): 100359, 2021 08 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34308389
12.
Editorial / Editorial
Artigo
em Espanhol
| InstitutionalDB, BINACIS, UNISALUD | ID: biblio-1530679
13.
Utilización precoz de tocilizumab en pacientes internados con COVID-19 grave y crítica: un estudio multicéntrico en la Provincia de Buenos Aires / Early use of tocilizumab in hospitalized patients with severe and critical COVID-19 in the Province of Buenos Aires: a multicentric study
Medicina (B.Aires)
; 83(2): 190-201, jun. 2023. graf
Artigo
em Espanhol
|
LILACS-Express
| ID: biblio-1448621
14.
Efectividad de refuerzos homólogos y heterólogos luego de esquemas primarios con Sputnik V, Astra-Zeneca y Sinopharm durante el período omicron en adultos mayores de 50 años en la provincia de Buenos Aires / Effectiveness of homologous and heterologous boosters after primary regimens with Sputnik V, AstraZeneca, and Sinopharm during the omicron variant period in adults over 50 years old in the province of Buenos Aires
Salud publica: revista del Ministerio de salud de la provincia de Buenos Aires
; 1: s30087074/kt72juzpm, 20230000.
Artigo
em Espanhol
| InstitutionalDB, BINACIS, UNISALUD | ID: biblio-1517949
15.
Efectos de la pandemia en muertes no COVID-19: Análisis en la provincia de Buenos Aires, Argentina, 2020 / Effects of the pandemic on non-COVID-19 deaths: analysis in the province of Buenos Aires, Argentina, 2020
Rev. argent. salud pública
; 14 (Suplemento COVID-19), 2022;14: 1-6, 02 Febrero 2022.
Artigo
em Espanhol
| LILACS, ARGMSAL, BINACIS | ID: biblio-1354567
16.
Sobrevida en pacientes internados en unidades de cuidados intensivos por COVID-19 en la provincia de Buenos Aires, Argentina / Survival in patients admitted to intensive care units due to COVID-19 in the province of Buenos Aires, Argentina
Rev. argent. salud pública
; 14 (Suplemento COVID-19), 2022;14: 1-7, 02 Febrero 2022.
Artigo
em Espanhol
| LILACS, ARGMSAL, BINACIS | ID: biblio-1367409
17.
Effects of the pandemic on non-COVID-19 deaths: analysis in the province of Buenos Aires, Argentina, 2020 / Efectos de la pandemia en muertes no covid-19: análisis en la provincia de buenos aires, argentina, 2020
Rev. argent. salud publica
; 14(supl.1): 46-46, feb. 2022. graf
Artigo
em Espanhol
|
LILACS-Express
| ID: biblio-1387617
18.
Survival in patients admitted to intensive care units due to COVID-19 in the province of Buenos Aires, Argentina / Sobrevida en pacientes internados en unidades de cuidados intensivos por covid-19 en la provincia de buenos aires, argentina
Rev. argent. salud publica
; 14(supl.1): 48-48, feb. 2022. graf
Artigo
em Espanhol
|
LILACS-Express
| ID: biblio-1387619
19.
Antibody durability at 1 year after Sputnik V vaccination.
Lancet Infect Dis
; 22(5): 589-590, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35305316
20.
Impacto de vacunación de COVID-19 en las infecciones por SARS-COV-2 en personal de salud de la provincia de Buenos Aires / Impact of vaccines against COVID-19 on new SARS-COV2 infections in health care workers of the Province of Buenos Aires
Rev. argent. salud publica
; 13(Suplemento COVID-19): 1-9, 2021.
Artigo
em Espanhol
| LILACS, ARGMSAL, BINACIS | ID: biblio-1284379